Dosage of insulin injections remains a complex issue for diabetes patients. The interplay between food intake, exercise and insulin leads to many judgement calls about when and how much insulin to inject, followed by more data collection to review the success or issues with such treatment. Now, Novo Nordisk has teamed up with IBM Watson Health to create a "virtual doctor" that will leverage artificial intelligence and draw on a broader set of data.
Source: Wall Street Journal (paywall)
Bytes on IBM Watson Health: Back in September of this year, IBM opened up its new health services business center right here in Cambridge, Massachusetts. Watson Health was the first targeted effort towards a specific vertical (followed quickly by cognitive computing), but official efforts in insurance, retail and others are sure to follow. The goal? $10 billion in Watson revenue by 2023.